TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All Notifications
of of All Notifications
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Central Government exempts Tocilizumab and Amphotericin B from CGST; reduces tax on Remdesivir and others to 2.5%.</h1> The Central Government, under the Central Goods and Services Tax Act, 2017, has issued a notification exempting certain COVID-19 medicines from the central tax, effective from October 1, 2021, to December 31, 2021. Tocilizumab and Amphotericin B are exempt from CGST, while other medicines such as Remdesivir, Heparin, and Favipiravir are subject to a reduced rate of 2.5%. This decision is based on the recommendations of the Council and aims to address public interest during the pandemic.
TaxTMI 
TaxTMI 
